Mitsubishi Chemical Group 주식 (OTC: MTLHY)

에 대한 최신 뉴스 Mitsubishi Chemical Group (OTC:MTLHY) 주식

MITSUBISHI CHEMICAL

Mitsubishi Chemical Group Corp is a holdings company, which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into three segments based on product. The Industrial Materials segment, which generates the majority of revenue, sells chemicals and polymers, including industrial gases, petrochemicals, thermoplastics, polyethylene, and polypropylene. The Performance Products segment sells electronics and designed materials, including LED lighting and equipment, specialty chemicals, polyester and industrial films, and fibers. The Health Care segment sells pharmaceuticals to treat autoimmune diseases, diabetes and kidney diseases, central nervous system treatments, and vaccines. The majority of revenue comes from Japan.

Asia

Government

Regulations

Eurozone

Politics

Global

Markets

AHKSY

BASFY

MTLHY

SABRY

중국은 미국과 유럽 연합에서 만든 플라스틱에 대한 새로운 반덤핑 조사를 시작하면서 서구와의 현재 진행 중인 경제 전쟁에서 새로운 단계를 밟았다. 이번 조치는 최근 조 바이든 대통령이 주도한 중국산 수입품에 대한 관세 인상 등 서방 국가들의 최근 보호주의 조치에 대한 보복 조치로 읽힐 수 있다.

중국, 바이든의 관세에 대응하여 새로운 플라스틱 수입 조사로 반격: 6개 주식이 피해 우려

MITSUBISHI CH GRP U/ADR by Mitsubishi Chemical Group Corporation

Mitsubishi Chemical Group Corp

The chemical industry is well-positioned for significant long-term growth thanks to sustained demand across diverse sectors, a shift toward sustainability and green chemistry, and rapid digital transformation. So, it could be wise to invest in top chemical stocks NewMarket (NEU), Mitsubishi Chemical Group (MTLHY), and ChromaDex (CDXC) for substantial gains. Keep reading… Chemicals have extensive application across various industries and, hence, are fundamental to the nation's economy. In addition, ongoing trends such as a growing shift toward sustainability and rapid digitalization and Industry 4.0 would propel the chemical sector's prospects.
Given the industry's bright outlook, it could be ideal to consider investing in fundamentally sound chemical stocks NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>), Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>), and ChromaDex Corporation (<a href="https://stocknews.com/stock/CDXC/">CDXC</a>) for accelerating returns.
The U.S. holds a substantial position in the global regime as the world's largest national producer of chemical products. The chemical sector in the U.S. is responsible for <a href="https://www.cisa.gov/sites/default/files/2023-02/chemical_sector_profile_final_508_2022_0.pdf">converting raw materials into more than 70,000 diverse products</a> necessary for modern life; these products are distributed to around 750,000 end users throughout the nation.
The chemical industry accounts for about 25% of the U.S. GDP as it supports the production of almost all commercial and household goods and is essential to economic growth. The employment generations from the chemical market are also significantly contributing to the overall growth of the economy.
The <a href="https://www2.deloitte.com/us/en/insights/industry/oil-and-gas/chemical-industry-outlook.html?id=us:2ps:3gl:chemout24:awa:industryoutlook:011824:chemical%20industry%20outlook:b:c:kwd-298218222617&amp;gad_source=1&amp;gclid=Cj0KCQiAzoeuBhDqARIsAMdH14HsFwgJADITYMg46e-TfYcieCncIA_-WgF13LelP3WQnMdGxcfk0PsaAnk7EALw_wcB">American Chemistry Council</a> expects that capital spending in the U.S. chemical industry will remain stable in 2024 before ramping up to a growth rate of 3% to 4% annually in 2025-2026.
In the near future, the energy transition will generate a wave of manufacturing activities that rely on chemicals and materials for support. Some of the critical factors investigated for 2024 growth are the regional competitive landscape, circular economy, sustainability and trust, and digital and artificial intelligence.
The global chemicals market size is expected to grow from $5.11 trillion in 2023 to $5.57 trillion in 2024 at a CAGR of 9%. Further, the market is anticipated to reach a volume of $7.79 trillion by 2028, <a href="https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report">growing at a CAGR of 8.7%</a>.
The growth in the forecast period is attributable to factors like evolving consumer preferences, renewable and bio-based materials, and health and safety prioritization. Major trends like smart manufacturing and <a href="https://www2.deloitte.com/content/dam/Deloitte/de/Documents/consumer-industrial-products/Deloitte-Industry-4.0-and-the-chemicals-industry.pdf">Industry 4.0</a>, sustainability and green chemistry, and advanced materials and nanotechnology will boost the market's expansion.
In recent years, demand for specialized performance chemicals from the agrochemical industry has been surging. They are used in several applications across the industrial, cosmetics, construction, electronics, and mining sectors. The specialty chemicals market is estimated to total $937.28 billion by 2028, expanding <a href="https://www.thebusinessresearchcompany.com/report/speciality-chemicals-global-market-report">at a CAGR of 4.9%</a>.
In light of these encouraging trends, let's look at the fundamentals of the three best <a href="https://stocknews.com/category/chemicals/">Chemicals</a> stocks, beginning with number 3.
Stock #3: NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>)
NEU engages in the manufacture and sale of petroleum additives. It provides lubricant additives for use in vehicle and industrial applications, engine oil additives designed for passenger cars, driveline additives for products like transmission fluids, and industrial additives designed for products for industrial applications consisting of hydraulic fluids.
On January 17, NEU completed the acquisition of AMPAC Intermediate Holdings, LLC, the parent company of American Pacific Corporation (AMPAC), for nearly $700 million. Located in Cedar City, Utah, AMPAC is the leading North American manufacturer of critical performance additives used in solid rocket motors for space launch and military defense applications.
"While we remain committed to our core petroleum additives business, we are also committed to identifying terrific opportunities outside of the petroleum additives business that meet our M&amp;A and diversification criteria. We think the acquisition of AMPAC is a great example of that approach," said NEU's Chairman and CEO, Thomas E. Gottwald.
On October 26, NEU's Board of Directors declared a quarterly dividend of $2.25 per share on the common stock of the Corporation. The dividend was paid on January 2, 2024, to NEU's shareholders of record at the close of business on December 15, 2023.
NEU pays an annual dividend of $9, which translates to a yield of 1.53% at the current share price. Its four-year average dividend yield is 2.20%. Moreover, the company's dividend payouts have increased at a CAGR of 5.2% over the past three years. NewMarket has raised its dividends for five consecutive years.
In the fiscal year that ended December 31, 2023, NEU reported a <a href="https://www.investopedia.com/terms/n/netsales.asp">net sales</a> of $2.70 billion. Its income before income tax expense increased 40.6% from the prior year to $488.96 million. Also, its net income grew 39.1% year-over-year to $388.86 million. Its earnings per share came in at $40.44, up 45.6% from the previous year.
As of December 31, 2023, the company's cash and cash equivalents came in at $111.94 million, compared to $68.71 million as of December 31, 2022.
NEU's stock gained 26.1% over the past six months and 63.0% over the past year to close the last trading session at $582.83.
NEU's robust outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
The stock has an A grade for Quality and a B for Stability and Sentiment. NEU is ranked #8 of 84 stocks within the <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry.
To see additional POWR Ratings of NEU for Growth, Value, and Momentum, <a href="https://stocknews.com/stock/NEU/">click here</a>.
Stock #2: Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>)
Headquartered in Tokyo, Japan, MTLHY offers performance products, chemicals, industrial gases, health care products, and other products internationally. It provides polyester films for various applications, industrial materials, and packaging materials for food and other products. It also offers high-performance engineering plastics.
On January 26, MTLHY announced the commencement of full-fledged verification testing for the world's first commercialization of polycarbonate resin chemical recycling. The company is conducting testing to collect polycarbonate resin from the headlamps of end-of-life vehicles.
The testing is being conducted in collaboration with Tokio Marine &amp; Nichido and ABT Corporation.
On January 25, MTLHY announced that its DURABIO&#x2122; plant-derived bioengineering plastic product was chosen by Panasonic Entertainment &amp; Communication Co., Ltd. for its Technics True Wireless Earbuds EAH-AZ80, which were placed on the market on June 15, 2023. The earbuds are the first product in their category to adopt the material.
MTLHY will continue to supply high-value-added performance products through developing DURABIO&#x2122; alongside contributing to the realization of a sustainable society.
For the nine months that ended December 31, 2023, MLTHY reported a sales revenue of ¥3.24 trillion ($21.84 billion). The company's gross profit increased marginally year-over-year to ¥856.04 billion ($5.76 billion). Its operating income grew 337% from the year-ago value to ¥212.50 billion ($1.43 billion).
In addition, the company's net income and EPS came in at ¥144.27 billion ($971.18 million) and ¥69.88, up 222.0% and 505.0% from the prior year's period, respectively.
Analysts expect MTLHY's revenue for the fiscal year (ending March 2024) to increase 3382.8% year-over-year to $30.31 billion. Likewise, the company's revenue for the fiscal year 2025 is expected to grow 2.9% from the prior year to $31.20 billion.
Over the past six months, the stock has gained 1.6% and 11.4% over the past year to close the last trading session at $29.80.
MTLHY's POWR Ratings reflect its bright prospects. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
The stock has an A grade for Value and Stability and a B for Quality. Within the Chemicals industry, MTLHY is ranked #2 out of 84 stocks.
<a href="https://stocknews.com/stock/MTLHY/">Click here</a> to access the other ratings of MTLHY for Growth, Momentum, and Sentiment.
Stock #1: ChromaDex Corporation (<a href="https://stocknews.com/stock/CDXC/">CDXC</a>)
CDXC operates as a bioscience company that focuses on developing healthy aging products. It operates through three segments: Consumer Products; Ingredients; and Analytical Reference Standards and Services. The company researches nicotinamide adenine dinucleotide (NAD+) and provides finished dietary supplement products.
On December 12, 2023, CDXC partnered with Neurohacker Collective, an acclaimed American science team that has been formulating advanced nutritional supplements since 2015, to create an NAD+ supplement called Qualia NAD+ that tackles the challenge of boosting NAD+ levels in aging Americans.
ChromaDex Senior Vice President of Business Development, Jason Campbell said: "Created with the highest scientific rigor and quality standards, our patented Niagen NR ingredient is the most efficient precursor available because it can cross the cell membrane directly."
On November 1, CDXC launched its clinical strength Tru Niagen&#xAE; Pro 1,000mg, featuring 1,000mg of Niagen&#xAE; (patented Nicotinamide Riboside or NR), one of the most efficient and superior quality NAD+ precursors on the market, to consumers nationwide.
Tru Niagen&#xAE; Pro 1,000mg is recommended by physicians and is used by pro athletes as a clinically proven alternative to boost NAD+ levels by up to 150% in just three weeks.
During the third quarter that ended September 30, 2023, CDXC's sales increased 14.2% year-over-year to $19.49 million. The company's gross profit rose 17.3% from the year-ago value to $11.97 million. Its adjusted EBITDA came in at $504 thousand, compared to a negative adjusted EBITDA of $1.21 million in the prior year's quarter.
Also, the company's cash and cash equivalents were $26.77 million as of September 30, 2023, compared to $20.44 million as of December 31, 2022.
Street expects CDXC's revenue for the fiscal year (ended December 2023) to grow 15.4% year-over-year to $83.16 million. For the first quarter ending March 2024, its revenue is expected to increase 4.7% year-over-year to $23.62 million. Further, the company has surpassed the consensus EPS estimates in all trailing four quarters, which is remarkable.
Shares of CDXC have surged 5.4% over the past month to close the last trading session at $1.55.
CDXC's sound fundamentals are reflected in its POWR Ratings. The stock has an overall rating of A, which translates to Strong Buy in our proprietary rating system.
CDXC has an A grade for Sentiment and a B for Value and Quality. It is ranked first among 84 stocks in the same industry.
<a href="https://stocknews.com/stock/CDXC/">Click here</a> to access additional CDXC ratings for Growth, Stability, and Momentum.
What To Do Next?
43 year investment veteran, Steve Reitmeister, has just released his 2024 market outlook along with trading plan and top 11 picks for the year ahead.
<a href="https://report.stocknews.com/sign-up/stock-market-outlook-2024/?formplacement=artbotad_smo24_rep">2024 Stock Market Outlook &gt;</a>

<hr />
MTLHY shares were unchanged in premarket trading Tuesday. Year-to-date, MTLHY has declined -0.90%, versus a 3.63% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Mangeet Kaur Bouns</h2> <img src='https:/wp-content/uploads/2022/01/Mangeet-Kaur-Bouns_Image-4.jpg' style="float:left; padding:5px;width:125px;">Mangeet's keen interest in the stock market led her to become an investment researcher and financial journalist. Using her fundamental approach to analyzing stocks, Mangeet's looks to help retail investors understand the underlying factors before making investment decisions.<a href="https://stocknews.com/authors/?author=mangeet-kaurbouns">More...</a>The post <a href=https://stocknews.com/news/mtlhy-neu-cdxc-top-3-accelerating-chemical-stocks-to-consider/>Top 3 Accelerating Chemical Stocks to Consider</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Top 3 Accelerating Chemical Stocks to Consider

Rising demand, emerging technologies, and improved operational efficiency drive the chemical industry's growth. Thus, quality chemical stocks Toray Industries (TRYIY), Mitsubishi Chemical Group (MTLHY), and ChromaDex (CDXC) might be ideal buys now for substantial returns. Read more… The chemical industry is well-positioned for long-term growth thanks to the high demand for specialty chemicals and the integration of digital technology. So, quality chemical stocks Toray Industries, Inc. (<a href="https://stocknews.com/stock/TRYIY/">TRYIY</a>), Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>), and ChromaDex Corporation (<a href="https://stocknews.com/stock/CDXC/">CDXC</a>) could be worth buying.
Before delving deeper into their fundamentals, let's discuss what's happening in the chemical industry.
The American Chemistry Council (ACC) U.S. Chemical Production Regional Index (U.S. CPRI) <a href="https://www.americanchemistry.com/chemistry-in-america/news-trends/weekly-economic-report/2024/weekly-chemistry-and-economic-trends-march-22-2024">increased by 0.4% in February</a>, following a 0.1% drop in January. Compared to February of the previous year, output increased by 2.0%, with year-over-year growth across all regions (excluding the Northeast).
The global chemicals market is expected to be worth $982.20 billion by 2030, registering a <a href="https://www.verifiedmarketresearch.com/product/chemical-industry-market/">CAGR of 4.8%</a>. The rising demand for inorganic chemicals in the fertilizer industry is expected to propel the chemicals market forward, as these chemicals improve plant growth and productivity.
The agrochemical industry's demand for specialized performance chemicals has increased significantly in recent years. They have a wide range of applications in sectors such as manufacturing, cosmetics, construction, electronics, and mining. The specialty chemicals market is estimated to total $762.08 billion by 2030, expanding at a <a href="https://www.nextmsc.com/report/specialty-chemicals-market">CAGR of 4.4%</a>.
In light of these encouraging trends, let's examine the fundamentals of the three <a href="https://stocknews.com/category/chemicals/">Chemicals</a> stocks, beginning with the third pick.
Stock #3: Toray Industries, Inc. (<a href="https://stocknews.com/stock/TRYIY/">TRYIY</a>)
Headquartered in Tokyo, Japan, TRYIY, together with its subsidiaries, manufactures, processes, and sells fibers and textiles, performance chemicals, carbon fiber composite materials, environment and engineering products, and life science products in Japan, China, North America, Europe, and internationally.
TRYIY's forward <a href="https://www.investopedia.com/terms/e/enterprisevaluesales.asp">EV/Sales</a> of 0.79x is 51.5% lower than the industry average of 1.63x. Its forward Price/Sales multiple of 0.46 is 63.4% lower than the industry average of 1.27.
TRYIY's trailing-12-month asset turnover ratio of 0.73x is 5.5% higher than the 0.69x industry average.
For the nine months ended December 31, 2023, TRYIY's revenues stood at ¥1.83 trillion ($12.09 billion), while its operating income came in at ¥71.37 billion ($471.68 million). Its profit and EPS came in at ¥45.66 billion ($301.76 million) and ¥28.46, respectively.
Also, its total assets came in at ¥3.39 trillion ($22.39 billion) for the period that ended December 31, 2023, compared to ¥3.19 trillion ($21.11 billion) for the period that ended March 31, 2023.
For the quarter ending June 30, 2024, TRYIY's revenue is expected to increase marginally year-over-year to $4.07 billion. Over the past month, the stock has gained 5.8% to close the last trading session at $9.71.
TRYIY's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect this promising outlook. It has an overall rating of A, equating to a Strong Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
TRYIY has an A grade for Stability and a B for Growth, Value, and Momentum. Within the B-rated <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry, it is ranked #3 out of 82 stocks. To see the additional ratings of TRYIY for Sentiment and Quality, <a href="https://stocknews.com/stock/TRYIY/">click here</a>.
Stock #2: Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>)
Headquartered in Tokyo, Japan, MTLHY offers performance products, chemicals, industrial gasses, health care products, and other products internationally. It provides polyester films for various applications, industrial and packaging materials for food and other products. It also offers high-performance engineering plastics.
MTLHY's forward EV/EBITDA of 6.79x is 19.4% lower than the industry average of 8.43x. Its forward Price/Sales multiple of 0.30 is 76.1% lower than the industry average of 1.27.
MTLHY's trailing-12-month levered FCF margin of 6.40% is 22.7% higher than the 5.21% industry average. Its trailing-12-month Return on Common Equity of 11.44% is 77.2% higher than the 6.46% industry average. Additionally, its 6.99% trailing-12-month Return on Total Capital is 38.4% higher than the 5.06% industry average.
For the nine months that ended December 31, 2023, MTLHY reported a sales revenue of ¥3.24 trillion ($21.84 billion). The company's gross profit increased marginally year-over-year to ¥856.04 billion ($5.76 billion). Its operating income grew 337% from the year-ago value to ¥212.50 billion ($1.43 billion).
In addition, the company's net income and EPS came in at ¥144.27 billion ($971.18 million) and ¥69.88, up 222.0% and 505.0% from the prior-year period, respectively.
Street expects MTLHY's revenue for the year ending March 31, 2024, to increase significantly year-over-year to $28.97 billion. Over the past month, the stock has gained 10.1% to close the last trading session at $30.90.
MTLHY's strong fundamentals are reflected in its POWR Ratings. It has an overall rating of A, which equates to a Strong Buy in our proprietary rating system.
It is ranked #2 in the same industry. It has an A grade for Value and Stability and a B for Growth and Quality. <a href="https://stocknews.com/stock/MTLHY/">Click here</a> to see the additional ratings of MTLHY for Momentum and Sentiment.
Stock #1: ChromaDex Corporation (<a href="https://stocknews.com/stock/CDXC/">CDXC</a>)
CDXC operates as a bioscience company that focuses on developing healthy aging products. It has three segments: Consumer Products; Ingredients; and Analytical Reference Standards and Services. The company researches nicotinamide adenine dinucleotide (NAD+) and provides finished dietary supplement products.
CDXC's forward EV/Sales of 2.74x is 25.3% lower than the industry average of 3.66x. Its forward Price/Sales multiple of 2.99 is 22.2% lower than the industry average of 3.83.
CDXC's trailing-12-month gross profit margin of 60.76% is 6.7% higher than the industry average of 56.93%. Its 11.33% trailing-12-month levered FCF margin is significantly higher than the 0.78% industry average. Its 1.53x trailing-12-month asset turnover ratio is 291.2% higher than the 0.39x industry average.
During the fourth quarter that ended December 31, 2023, CDXC's sales increased marginally year-over-year to $21.20 million. The company's gross profit rose 7.7% from the year-ago value to $12.94 million. Its adjusted EBITDA came in at $1.25 million, an increase of 256.3% year-over-year.
Also, the company's cash and cash equivalents were $27.33 million as of December 31, 2023, compared to $20.44 million as of December 31, 2022.
Analysts expect CDXC's EPS for the year ending December 31, 2025, to increase significantly year-over-year to $0.06. Its revenue is expected to grow 17.7% year-over-year to $114.28 million for the same period. CDXC shares have gained 168.5% over the past six months, closing the last trading session at $3.84.
It's no surprise that CDXC has an overall A rating, equating to a Strong Buy in our POWR Ratings system.
It has an A grade for Quality and a B for Growth and Sentiment. It is ranked first in the Chemicals industry.
Beyond what is stated above, we've also rated CDXC for Value, Momentum, and Stability. Get all CDXC ratings <a href="https://stocknews.com/stock/CDXC/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
MTLHY shares were trading at $30.90 per share on Wednesday afternoon, up $0.17 (+0.54%). Year-to-date, MTLHY has gained 2.76%, versus a 9.65% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rashmi Kumari</h2> <img src='https:/wp-content/uploads/2022/10/Rashmi-Kumari_headshot_2-1.jpg' style="float:left; padding:5px;width:125px;">Rashmi is passionate about capital markets, wealth management, and financial regulatory issues, which led her to pursue a career as an investment analyst. With a master's degree in commerce, she aspires to make complex financial matters understandable for individual investors and help them make appropriate investment decisions.<a href="https://stocknews.com/authors/?author=rashmi-kumari">More...</a>The post <a href=https://stocknews.com/news/mtlhy-tryiy-cdxc-3-chemical-stocks-poised-for-gains/>3 Chemical Stocks Poised for Gains</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Chemical Stocks Poised for Gains

Blackstone, Bain to bid for Mitsubishi pharma unit - Reuters

Mitsubishi Chemical Group is a holdings company, which manufactures and sells chemicals, plastics, and pharmaceuticals.

Stock Analysis: Mitsubishi Chemical

CDXC

MTLHF

TRYIY

Mitsubishi Chemical Group

중국은 <a href="https://www.benzinga.com/topic/china" target="_blank" rel="noopener">미국과 유럽 연합에서 만든</a> 플라스틱에 대한 새로운 반덤핑 조사를 시작하면서 서구와의 현재 진행 중인 경제 전쟁에서 새로운 단계를 밟았다.
이번 조치는 최근 조 바이든 대통령이 주도한 <a href="https://www.benzinga.com/markets/asia/24/05/38824198/biden-announces-massive-tariffs-on-chinese-imports-to-protect-us-industries-clean-energy-solar-stock" target="_blank" rel="noopener">중국산 수입품에 대한 관세 인상</a> 등 서방 국가들의 최근 보호주의 조치에 대한 보복 조치로 읽힐 수 있다.
중국 상무부는 지난 일요일 가전제품, 가정용품, 자동차 부품은 물론 산업 응용 분야에 널리 사용되는 플라스틱 유형인 폴리옥시메틸렌 공중합체의 수입을 조사하는 내용의 조사를 발표했다.
이 물질을 제조하는 공개 기업들로는 셀라니즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>),바스프 SE(OTC:<a class="ticker" href="https://www.benzinga.com/stock/BASFY#OTC">BASFY</a>),듀폰(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>),미쓰비시 케미컬 홀딩스(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MTLHY#OTC">MTLHY</a>), 아사히 카세이(OTC:<a class="ticker" href="https://www.benzinga.com/stock/AHKSY#OTC">AHKSY</a>) 및 사빅(SABIC) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SABRY#OTC">SABRY</a>)이 있다.
내년에 중국은 수입품의 가격이 국내 시장과 동일한 수준인지 알아보기 위해 미국, 일본, 대만, EU에서 들어오는 아세탈 또는 POM이라고도 알려진 화학 물질의 수입을 조사할 것이다.
반덤핑 조사에서 국가는 시장 점유율을 확보하고 현지 경쟁을 제압하기 위해 다른 국가의 기업이 낮은 가격으로 품목 가격을 책정하는지 여부를 평가하려고 한다.
이 조사는 1년 기간이 완료된 후 6개월 동안 연장될 수 있다.
다음 글도 읽기: <a href="https://www.benzinga.com//node/38915754">중국 전기차 업체 리 오토, 1분기 매출 예상치 못미치다</a>
중국의 보복? 지난주 바이든의 조치는 미국의 제조업 일자리를 보호하기 위해 중국 상품에 더 높은 관세를 부과하는 계획을 앞당겨 중국에 큰 충격을 안겼다.
이번 조치에는 중국 철강 및 알루미늄에 대한 25% 관세, 중국 전기차에 대한 신규 100% 관세, 전기차용 배터리 및 중요한 광물에 대한 25% 관세, 25%에서 50%로 올라간 중국 태양광 패널에 대한 관세, 그리고 중국에서 생산된 반도체에 대한 새로운 50% 관세가 포함돼 있다.
이렇게 된 결정은 미국 자동차 제조업체인 포드 자동차(NYSE:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/f" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for F">F</a>)와 제너럴 모터스(NYSE:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/gm" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for GM">GM</a>)에 <a href="https://www.benzinga.com/markets/equities/24/05/38839620/bidens-new-tariffs-on-chinese-imports-are-a-clear-giveaway-to-these-two-tesla-rivals-jim-cramer-">직접적인 혜택을 준다고 한다</a>.
바이든의 최근 조치는 미국의 일자리와 산업 역량을 보호하기 위한 보호주의 조치를 추진해 아직 결정을 내리지 못한 유권자들을 끌어들이기 위한 전면적인 캠페인의 일환이다. 가장 최근 여론조사에 따르면, 최근 몇 년 동안 더욱 보호주의적이고 반중적인 담론을 자랑해 온 공화당 상대 도널드 트럼프가 <a href="https://www.benzinga.com/general/politics/24/05/38923614/trump-vs-biden-hush-money-trial-fails-to-dampen-support-trump-maintains-1-point-lead-in-2024-ele" target="_blank" rel="noopener">1점 차로 앞서고</a> 있다.
EU, 중국 전기차, 철강 등에 주목: 바이든의 새로운 관세는 트럼프 대통령이 전 백악관 행정부 시절 부과했던 관세를 바탕으로 이뤄졌다. 이 새로운 관세 발표는 대서양 건너편에서 오는 중국 국제 무역에 대한 또 다른 타격과 동시에 이루어졌다.
유럽연합(EU)의 집행기관인 유럽연합 집행위원회는 미국처럼 중국 전기차에 관세를 부과해야 할지 여부에 대한 <a href="https://www.benzinga.com/government/24/01/36751546/xi-jinping-representative-slams-eu-for-unfair-probe-into-ev-subsidies-mostly-targeted-at-china">조사</a>가 절반 정도 진행 중이다.
유럽연합 집행위원회가 수행하는 이 조사는 중국에서 수입되는 철강 제품과 목재 바닥재, 의료 기기를 중심으로 이루어지고 있다.
로이터 통신에 따르면 풍력 터빈, 태양광 패널 등 청정 에너지 생산과 관련된 여러 중국 제품도 블록에서 조사되고 있다.
이제 다른 기사 읽기: <a href="https://www.benzinga.com//node/38912375">영국의 전 총리, 테슬라의 &#8216;FSD&#8217; 시스템에 감탄</a>
썸네일 제공

Comments

Mitsubishi Chemical Group

뉴스

에 대한 최신 뉴스 Mitsubishi Chemical Group (OTC:MTLHY) 주식

월요일, 5월 20, 2024

뉴스

파트너 / 기고자

벤징가 글로벌